Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

Active, not recruiting

Conditions: Multiple Myeloma
Myelodysplastic Syndrome
Acute Leukemia
Acute Lymphoblastic Leukemia

First Posted Date: 2003-01-27

Last Posted Date: 2024-07-31

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 9000

Registration Number: NCT00048958

Locations: 🇺🇸
Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States
🇺🇸
Camino Medical Group - Treatment Center, Mountain View, California, United States
🇺🇸
Kaiser Permanente Medical Office -Vandever Medical Office, San Diego, California, United States

and more 134 locations

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: filgrastim
Biological: rituximab
Drug: cyclophosphamide
Drug: doxorubicin hydrochloride
Drug: etoposide
Drug: prednisone
Drug: vincristine sulfate

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-19

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 78

Registration Number: NCT00032019

Locations: 🇺🇸
Northeast Alabama Regional Medical Center, Anniston, Alabama, United States
🇺🇸
Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States
🇺🇸
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States

and more 78 locations

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma

Phase 2

Completed

Conditions: Lymphoma
Graft Versus Host Disease

Interventions: Drug: carmustine
Drug: melphalan
Drug: etoposide
Drug: cytarabine
Drug: tacrolimus
Drug: methotrexate
Drug: sargramostim
Procedure: transplant

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-19

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 4

Registration Number: NCT00006747

Locations: 🇺🇸
Veterans Affairs Medical Center - Birmingham, Birmingham, Alabama, United States
🇺🇸
University of California San Diego Cancer Center, La Jolla, California, United States
🇺🇸
Veterans Affairs Medical Center - San Francisco, San Francisco, California, United States

and more 45 locations

Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer

Phase 3

Completed

Conditions: Prostate Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 190

Registration Number: NCT00023686

Locations: 🇺🇸
St. Vincent Cancer Center, Little Rock, Arkansas, United States
🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States
🇺🇸
Walter Reed Army Medical Center, Washington, District of Columbia, United States

and more 33 locations

Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer

Not Applicable

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2016-12-07

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 161

Registration Number: NCT00042926

Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease

Phase 2

Completed

Conditions: Hot Flashes
Hot Flushes
Breast Cancer

Interventions: Dietary Supplement: soy protein
Dietary Supplement: isoflavones
Other: Placebo
Drug: Tamoxifen

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 112

Registration Number: NCT00031720

Locations: 🇺🇸
Center for Cancer Care at OSF Saint Anthony Medical Center, Rockford, Illinois, United States
🇺🇸
Elkhart General Hospital, Elkhart, Indiana, United States
🇺🇸
Howard Community Hospital, Kokomo, Indiana, United States

and more 11 locations

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

Phase 2

Completed

Conditions: Malignant Mesothelioma

Interventions: Drug: epirubicin hydrochloride
Drug: gemcitabine hydrochloride

First Posted Date: 2003-01-27

Last Posted Date: 2016-12-07

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 69

Registration Number: NCT00017186

Locations: 🇺🇸
MBCCOP - Gulf Coast, Mobile, Alabama, United States
🇺🇸
CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States

and more 21 locations

Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: carboplatin
Drug: gemcitabine hydrochloride
Drug: paclitaxel
Radiation: radiation therapy

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-19

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 69

Registration Number: NCT00033553

Locations: 🇺🇸
Northeast Alabama Regional Medical Center, Anniston, Alabama, United States
🇺🇸
Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States
🇺🇸
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States

and more 71 locations

Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Phase 3

Completed

Conditions: Head and Neck Cancer
Radiation Toxicity
Oral Complications
Dysgeusia

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-14

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 173

Registration Number: NCT00036881

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Phase 3

Completed

Conditions: Sarcoma
Diarrhea
Colorectal Cancer
Prostate Cancer
Vaginal Cancer
Cervical Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Vulvar Cancer
Endometrial Cancer
Fallopian Tube Cancer

Interventions: Other: placebo
Drug: octreotide acetate
Radiation: radiation

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 130

Registration Number: NCT00033605

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy